Ads
related to: afrezza inhaled insulin- Patient Support
Discover Support For Patients
On Their T1D Journey
- Learn About T1D Treatment
Discover T1D Treatment for
Appropriate Patients
- Patient Support
Search results
A Complete Guide to Type 1 Diabetes Medications
Verywell Health via Yahoo News· 3 hours agoInsulin is the most common medication used to treat type 1 diabetes. Learn more about insulin and other medications often prescribed to help manage this...
Insulin vs. Blood Sugar: Understanding How to Manage Diabetes
Verywell Health via Yahoo News· 2 years agoInsulin helps lower blood sugar, but with type 2 diabetes, this relationship doesn’t work properly....
MannKind (MNKD) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 weeks agoImage source: The Motley Fool. MannKind (NASDAQ: MNKD) Q1 2024 Earnings Call May 08, 2024, 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers...
MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoMannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript February 27, 2024 MannKind...
MannKind Corp (MNKD) Q1 2024 Earnings Call Transcript Highlights: A Quarter of Robust Growth ...
GuruFocus.com via Yahoo Finance· 4 weeks agoRevenue Growth: Increased by 63% year-over-year in Q1 2024. Net Income: Reported at $11 million in Q1 2024. Earnings Per Share (EPS): Achieved $0.04 in Q1 2024. Cash Position: Ended Q1 with ...
MannKind Corp (MNKD) Reports Substantial Revenue Growth in 2023
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenues: $199M in 2023, a 99% increase compared to $99.77M in 2022. Fourth Quarter Revenues: $58M in Q4 2023, up 62% from $36.06M in Q4 2022. Net Income: Achieved a net income of $1M ...
Q2 2023 MannKind Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 months agoParticipants Michael E. Castagna; CEO & Director; MannKind Corporation Steven B. Binder; CFO; MannKind Corporation Anthony Charles Petrone; MD of Senior Medical Devices, Diagnostics & Therapeutics ...
Why Shares of MannKind Are Up Wednesday
Motley Fool· 1 year agoShares of MannKind (NASDAQ: MNKD) were up 15.6% Wednesday morning after the company released first-quarter earnings after the market closed on Tuesday....
3 Biotech Stocks to Sell in August Before They Crash and Burn
InvestorPlace via Yahoo Finance· 10 months agoInvestors who’ve dipped their toe into the waters of biotech stocks know that the chances of these...
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
InvestorPlace via Yahoo Finance· 11 months agoThe tech and growth segments of the market have been having a tremendous 2023 with one glaring...
Ad
related to: afrezza inhaled insulin
